高级检索
当前位置: 首页 > 详情页

Emerging role of ferroptosis in diabetic retinopathy: a review

| 导出 | |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol,Dept Ophthalmol,Tongji Hosp,Tongji Med Coll,Wuhan 430030,Peoples R China
出处:
ISSN:

关键词: Diabetic retinopathy ferroptosis neuroinflammation oxidative stress lipid peroxidation

摘要:
BackgroundDiabetic retinopathy (DR) is a significant complication of diabetes and the primary cause of blindness among working age adults globally. The development of DR is accompanied by oxidative stress, characterised by an overproduction of reactive oxygen species (ROS) and a compromised antioxidant system. Clinical interventions aimed at mitigating oxidative stress through ROS scavenging or elimination are currently available. Nevertheless, these treatments merely provide limited management over the advanced stage of the illness. Ferroptosis is a distinctive form of cell death induced by oxidative stress, which is characterised by irondependent phospholipid peroxidation.PurposeThis review aims to synthesise recent experimental evidence to examine the involvement of ferroptosis in the pathological processes of DR, as well as to explicate the regulatory pathways governing oxidative stress and ferroptosis in retina.MethodsWe systematically reviewed literature available up to 2023.ResultsThis review included 12 studies investigating the involvement of ferroptosis in DR. Schematic diagram of potential pathways leading to DR caused by ferroptosis. Characteristic manifestations of DR in the retina include haemorrhage, hard exudation, angiogenesis, and neurodegeneration. Iron accumulation, lipid peroxidation, and impaired antioxidant defence systems induced ferroptosis in diabetic retinopathy, resulting in compromised retinal cell viability, disrupted cell-to-cell junctions, and elicited inflammatory responses.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2022]版:
Q2 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol,Dept Ophthalmol,Tongji Hosp,Tongji Med Coll,Wuhan 430030,Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)